Status:
UNKNOWN
Imaging for Significant Prostate Cancer Risk Evaluation
Lead Sponsor:
University College London Hospitals
Collaborating Sponsors:
Advanced Medical Diagnostics s.a.
Conditions:
Prostate Cancer
Eligibility:
MALE
20+ years
Phase:
NA
Brief Summary
The incidence of prostate cancer is rising however the number of deaths from prostate cancer is stable. Meaning the investigators are diagnosing many men with prostate cancer that will not impact on t...
Eligibility Criteria
Inclusion
- Men who have undergone prior trans-rectal biopsies.
- Men undergoing further evaluation of their prostate and who are seeking characterisation using Transperineal Template Prostate Mapping Biopsy.
Exclusion
- Previous history of prostate cancer treatment
- Men unable to have MRI scan, or in whom artefact would reduce quality of MRI.
- Men unable to have general or regional anaesthesia
- Men unable to give informed consent
Key Trial Info
Start Date :
December 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2013
Estimated Enrollment :
126 Patients enrolled
Trial Details
Trial ID
NCT01492270
Start Date
December 1 2011
End Date
July 1 2013
Last Update
December 30 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University College London Hospitals
London, London, United Kingdom, NW1 2PG